Health ❯ Healthcare ❯ Clinical Research

Phase 3 Trials

Randomized Controlled Trials HOPE-3 Trial Drug Efficacy Progression-Free Survival EULAR 2025 X-TOLE2 Study Eli Lilly's Orforglipron Patient Outcomes GRACE Trial STEP UP Trial Combination Therapy MajesTEC-3 Study Eli Lilly Trials Efficacy and Safety CORE and CORE2 Trials ATTAIN-1 Trial Viral Suppression Efficacy Studies SOUL Trial Novo Nordisk Weight Loss Efficacy Purpose Studies OASIS Trials Pirtobrutinib Weight Loss Medications STEER and STRENGTH Studies Olatorepatide

CHMP Recommends Adding Oral Wegovy Tablets to EU Approval

European Commission approval would create the first oral GLP‑1 for adult weight management with pricing left to EU Member States.

Sacituzumab Tirumotecan With Keytruda Improves Progression-Free Survival in China Phase 3 Lung Cancer Trial

Pfizer’s Elrexfio Posts Phase 3 PFS Win Over Standard Multiple Myeloma Regimen

Xenon Presents Phase 3 Azetukalner Results and 48‑Month Data at American Academy of Neurology Meeting

Single Daily Bictegravir–Lenacapavir Pill Matches Complex HIV Regimens in Phase III

FDA Issues Complete Response Letter for Corcept’s Relacorilant in Cushing’s-Related Hypertension

Roche’s Giredestrant Cuts Early Breast Cancer Recurrence 30% in Phase III Trial

FDA Approves One-Time Intrathecal Gene Therapy Itvisma for Older SMA Patients

J&J Myeloma Trial Stopped Early After Tecvayli–Darzalex Shows PFS and OS Benefit

FDA Opens Door to Reconsider Capricor’s Duchenne Cell Therapy Based on HOPE-3 Data

Ionis’ Olezarsen Slashes Triglycerides, Cuts Pancreatitis in Phase 3 Trials

Moderna Withdraws Flu-COVID Vaccine Application After FDA Requests More Data